Rituxan

Rituximab

Rituximab
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders.

Rituxan - List of case studies

Treatments

directed against compliment Antibody therapy (Rituxan) Anticholinergic agents Anticholinergic drugs ...

B-cell lymphoma

especially the combination with the antibody therapy (Rituxan), and also the RT. Indeed, Rituxan is capable of causing serious and prolonged neutropenia, even months, ...

Drugs

Rilutex Riluzole Riopan Risedronate Rituxan Rituximab Rofeoxib Roferon A 3000000 U ...

JustAnswer.com